SLC22A1 rs622342 Polymorphism Predicts Insulin Resistance Improvement in Patients with Type 2 Diabetes Mellitus Treated with Metformin: A Cross-Sectional Study
Background. Metformin is the most widely used oral antidiabetic agent and can reduce insulin resistance (IR) effectively. Organic cation transporter 1 (encoded by SLC22A1) is responsible for the transport of metformin, and ataxia-telangiectasia-mutated (ATM) is a gene relating to the DNA repair and...
Saved in:
Main Authors: | Kunrong Wu, Xiaoli Li, Yuedong Xu, Xiaoqian Zhang, Ziwan Guan, Shufang Zhang, Yan Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2020/2975898 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Impacts of SLC22A1 rs594709 and SLC47A1 rs2289669 Polymorphisms on Metformin Therapeutic Efficacy in Chinese Type 2 Diabetes Patients
by: Di Xiao, et al.
Published: (2016-01-01) -
SLC2A9 rs1014290 Polymorphism is Associated with Prediabetes and Type 2 Diabetes
by: Xuemei Zhang, et al.
Published: (2022-01-01) -
Metformin versus insulin in gestational diabetes mellitus: a systematic review
by: Giovanna Noronha Berti, et al.
Published: (2025-01-01) -
SLC6A4 5HTTLPR Polymorphism Affects Insulin Secretion in Patients with Polycystic Ovary Syndrome
by: Barbara Šenk, et al.
Published: (2018-01-01) -
Exenatide with Metformin Ameliorated Visceral Adiposity and Insulin Resistance
by: Xuan Du, et al.
Published: (2018-01-01)